Anika Therapeutics Posts Orthobiologics Sales Growth for 2Q17/1H17

Anika Therapeutics posted 2Q17 orthobiologic revenue of US $24.5MM, +5.0% vs. 2Q16, and 1H17 revenue of $44.7MM, +4.2% vs. 1H16.

Q17 
2Q16 
$ Change 
% Change 

 Orthobiologics
$24.5 
$23.3 ...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0